ALFA Finder| Margins | Gross margin expanded to 39.2% (up 111 bps); EBITDA margin at 21.9%. |
|---|---|
| Demand visibility | Subdued domestic demand; strong export growth in South America and Africa. |
| Management confidence | Resilient despite headwinds; focused on sustainable growth. |
Growth
Revenue +1% YoY; EBITDA +6% YoY; PAT +20% YoY. Export revenue grew 26% YoY, contributing 16% to total sales.
Outlook
Announced ₹160 cr total CAPEX for herbicide/fungicide manufacturing for parent company. New products Topgrain and Helibax set for Q2FY27 launch.
Risks
Delayed monsoon, 40% rainfall deficit, 20% decline in kharif sowing, and elevated channel inventories impacted domestic demand.
Last quarter's promises, checked
Delivered
- Restart animal nutrition distribution → Restarted in Q1FY27 (= BEAT)
- Launch biostimulant 'TopGrain' in upcoming months → Launching Q2FY27 (= BEAT)
- Maintain sustainable margins → Gross margin expanded to 39.2% (= BEAT)
Partly delivered
- Execute ₹150cr Dahej capex → Environmental clearance received; timeline Q2FY29 (= PARTIAL)
Missed
- Maintain sales at ₹110-140cr level → Revenue grew only 1% YoY (= MISS)
Investor Presentation filed with BSE, NSE: SUMICHEM. Summary written with AI assistance from the document.
Sumitomo Chemical India Ltd: key numbers
- Share price
- ₹350.95
- Market cap
- ₹17,518 Cr
- Revenue (annual)
- ₹3,238 Cr
- Net profit (annual)
- ₹543.0 Cr
- P/E (TTM)
- 31.3×Sector 35.5×
- Promoter holding
- 75.00%+0.00% QoQ
- FII holding
- 2.89%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Sumitomo Chemical India Ltd
All →Sumitomo Chemical India Earnings Call Transcript: Key Takeaways
Sumitomo Chemical delivered stable H1 performance despite India's fourth weakest monsoon since 2001. Management maintained 20%+ EBITDA margins through cost control and a 22% value growth in specialty products, offsetting volume declines in generic segments.
Sumitomo Chemical India Investor Presentation: Key Takeaways
Q2FY27 revenue Rs907 Cr (-2% YoY), PAT Rs157 Cr (-11%), EBITDA margin 20.5% (-297bps). H1FY27 PAT up 5% to Rs372 Cr on revenue down 1%. Volume-led weakness; inventory cost mismatch hit margins.
Sumitomo Chemical India Q2 FY27 Results: Net Profit ₹167.4 Cr, Down 5.8% YoY
Sumitomo Chemical India Ltd reported revenue from operations of ₹907.3 Cr (-2.4% YoY) and net profit of ₹167.4 Cr (-5.8% YoY) for Q2 FY27.
- Key figure
- Net profit ₹167.4 Cr · -5.8% YoY
Sumitomo Chemical India Q2 FY27 Results: Net Profit ₹157.4 Cr, Down 11.5% YoY
Sumitomo Chemical India Ltd reported revenue from operations of ₹907.3 Cr (-2.4% YoY) and net profit of ₹157.4 Cr (-11.5% YoY) for Q2 FY27.
- Key figure
- Net profit ₹157.4 Cr · -11.5% YoY
Sumitomo Chemical India Other Announcement
The company submitted its quarterly shareholding pattern for the period ended September 30, 2026, in compliance with SEBI Listing Regulations.
Sumitomo Chemical India Board Meeting Date
Sumitomo Chemical India Limited has scheduled a board meeting for October 26, 2026, to approve the standalone and consolidated financial results for the period ended September 2026.